Inventor · disambiguated record
Stephen J. Forman
Also filed as: FORMAN STEPHEN · FORMAN STEPHEN J
22 granted patents·32 pending applications·538 citations·filing 2001–2025
94Inventor score
Top patents by PatentIndex Score
54 records- 0197US7446179B2CD19-specific chimeric T cell receptorHOPE CITY·Filed 2001·Granted Nov 4, 2008·453 cites·5 claims
- 0294US9914909B2Costimulatory chimeric antigen receptor T cells targeting IL13Rα2HOPE CITY·Filed 2016·Granted Mar 13, 2018·21 cites·16 claims
- 0393US11730797B2CS1 targeted chimeric antigen receptor-modified T cellsHOPE CITY·Filed 2020·Granted Aug 22, 2023·3 cites·9 claims
- 0493US11197919B2Chimeric antigen receptors targeting HER2HOPE CITY·Filed 2016·Granted Dec 14, 2021·11 cites·60 claims
- 0592US12497440B2CS1 targeted chimeric antigen receptor-modified T cellsHOPE CITY·Filed 2023·Granted Dec 16, 2025·1 cites·14 claims
- 0692US12161714B2Use of endogenous viral vaccine in chimeric antigen receptor T cell therapyHOPE CITY·Filed 2023·Granted Dec 10, 2024·1 cites·6 claims
- 0791US10676717B2Costimulatory chimeric antigen receptor T cells targeting IL13Rα2HOPE CITY·Filed 2018·Granted Jun 9, 2020·5 cites·16 claims
- 0889US10821161B2CS1 targeted chimeric antigen receptor-modified T cellsHOPE CITY·Filed 2015·Granted Nov 3, 2020·4 cites·13 claims
- 0988US9657105B2CD123-specific chimeric antigen receptor redirected T cells and methods of their useFORMAN STEPHEN·Filed 2013·Granted May 23, 2017·30 cites·18 claims
- 1086US12478672B2Use of triplex CMV vaccine in CAR T cell therapyHOPE CITY·Filed 2023·Granted Nov 25, 2025·0 cites·10 claims
- 1184US10660916B2CD123-specific chimeric antigen receptor redirected T cells and methods of their useHOPE CITY·Filed 2017·Granted May 26, 2020·2 cites·18 claims
- 1282US11918606B2CD123-specific chimeric antigen receptor redirected t cells and methods of their useHOPE CITY·Filed 2020·Granted Mar 5, 2024·1 cites·20 claims
- 1382US11230577B2Chimeric antigen receptors containing a chlorotoxin domainHOPE CITY·Filed 2016·Granted Jan 25, 2022·3 cites·41 claims
- 1481US11701405B2Chimeric antigen receptors and methods for reducing toxicityHOPE CITY·Filed 2019·Granted Jul 18, 2023·1 cites·7 claims
- 1581US2025171518A1Methods for preparing cells for adoptive t cell therapyHOPE CITY·Filed 2024·Application pending·0 cites
- 1681US2024156928A1Bi-specific targeted chimeric antigen receptor t cellsHOPE CITY·Filed 2024·Application pending·0 cites
- 1779US2025333471A1Chimeric Antigen Receptors Targeting HER2HOPE CITY·Filed 2024·Application pending·0 cites
- 1876US11466097B2Chimeric antigen receptors targeted to PSCAHOPE CITY·Filed 2016·Granted Oct 11, 2022·1 cites·13 claims
- 1975US12281152B2TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumorsHOPE CITY·Filed 2019·Granted Apr 22, 2025·1 cites·42 claims
- 2075US2024415963A1T cells for expression of chimeric antigen receptors and other receptorsHOPE CITY·Filed 2024·Application pending·0 cites
- 2174US2025002850A1Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptorsHOPE CITY·Filed 2024·Application pending·0 cites
- 2271US2024148826A1Chimeric antigen receptors and methods for reducing toxicityHOPE CITY·Filed 2023·Application pending·0 cites
- 2369US12472233B2Administration of engineered T cells for treatment of cancers in the central nervous systemHOPE CITY·Filed 2020·Granted Nov 18, 2025·0 cites·16 claims
- 2469US2021386840A1Bi-specific targeted chimeric antigen receptor t cellsHOPE CITY·Filed 2021·Application pending·0 cites
- 2568US2022265796A1Chimeric antigen receptors targeting her2HOPE CITY·Filed 2021·Application pending·0 cites
- 2668US2024058382A1Deterministic mechanoporation for cell engineeringUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2766US2025381237A1Oncolytic virus expressing a car t cell target and uses thereofHOPE CITY·Filed 2025·Application pending·0 cites
- 2863US12496338B2CAR for treatment of HIV infectionHOPE CITY·Filed 2018·Granted Dec 16, 2025·0 cites·7 claims
- 2963US2020318069A1COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13R-alpha-2HOPE CITY·Filed 2020·Application pending·0 cites
- 3063US2021102165A1Methods for preparing cells for adoptive t cell therapyHOPE CITY·Filed 2020·Application pending·0 cites
- 3163US2025263463A1Deterministic mechanoporation for cell engineeringUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 3261US12364724B2Oncolytic virus expressing a car T cell target and uses thereofHOPE CITY·Filed 2018·Granted Jul 22, 2025·0 cites·11 claims
- 3360US2025249102A1Cmv-hiv specific chimeric antigen receptor t cellsHOPE CITY·Filed 2023·Application pending·0 cites
- 3460US2022177528A1Chimeric antigen receptors containing a chlorotoxin domainHOPE CITY·Filed 2021·Application pending·0 cites
- 3559US12115189B2T cells for expression of chimeric antigen receptors and other receptorsHOPE CITY·Filed 2016·Granted Oct 15, 2024·0 cites·7 claims
- 3658US11744862B2CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosisHOPE CITY·Filed 2018·Granted Sep 5, 2023·0 cites·11 claims
- 3757US2025320291A1Compositions and uses of cd19 targeted chimeric antigen receptor modified immune cellsHOPE CITY·Filed 2021·Application pending·0 cites
- 3857US2023338531A1Compositions and uses of cd45 targeted chimeric antigen receptor modified t cellsHOPE CITY·Filed 2021·Application pending·0 cites
- 3957US2018214527A1Bi-specific targeted chimeric antigen receptor t cellsHOPE CITY·Filed 2016·Application pending·0 cites
- 4056US2022362300A1Generation of chimeric antigen receptor modified t cells from stem cells and therapeutic uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
- 4154US2022072043A1Combination therapy comprising cancer-targeted car-t cells and a method of using same for a treatment for cancerMUSTANG BIO INC·Filed 2021·Application pending·0 cites
- 4254US2017224733A1Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous SystemHOPE CITY·Filed 2017·Application pending·0 cites
- 4354US2016333108A1CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USEFORMAN STEPHEN J·Filed 2014·Application pending·0 cites
- 4454US2020040096A1CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USEHOPE CITY·Filed 2018·Application pending·0 cites
- 4553US2020222462A1Methods of treatment using decitabine and a cd123-targeted therapyMUSTANG BIO INC·Filed 2019·Application pending·0 cites
- 4653US2020095547A1Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptorsALIZADEH DARYA·Filed 2017·Application pending·0 cites
- 4753US2020289568A1Deterministic mechanoporation for cell engineeringUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4851US2021379106A1Oxabicycloheptanes for enhancing car t cell functionLIXTE BIOTECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 4949US9347102B2Gene signatures for prediction of therapy-related myelodysplasia and methods for identification of patients at risk for development of the sameHOPE CITY·Filed 2013·Granted May 24, 2016·0 cites·1 claims
- 5049US2018320133A1Methods for preparing cells for adoptive t cell therapyHOPE CITY·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen J. Forman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →